Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Go back to Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
(NYSE: BHVN) Delayed: 13.57 -0.05 (0.37%)
Previous Close $13.62    52 Week High
Open $13.69    52 Week Low
Day High $14.23    P/E N/A 
Day Low $13.12    EPS
Volume 6,458,980